Itchy Skin, Low Blood Counts: Study Probes Anemia Risk in Children With Eczema

Atopic dermatitis, the most common chronic inflammatory skin disease of childhood, has long been viewed as a condition confined largely to the skin: dry, itchy, inflamed patches that flare and remit over years. But a growing body of research suggests that the consequences of eczema may extend well beyond the epidermis. A new systematic review and meta-analysis, published in the Archives of Dermatological Research by a team of dermatologists affiliated with the Renaissance School of Medicine at Stony Brook University and Stony Brook Dermatology, examines one of the less obvious potential complications of pediatric atopic dermatitis: anemia, a reduction in the blood’s oxygen-carrying capacity that can leave children fatigued, pale, and developmentally vulnerable.

The study, led by Dennis Chu and Ashley Yu, who contributed equally to the work, alongside William Guo, Joann Salvemini, Jeremy Hugh, and Neal Shah, was published as a research letter on 20 September 2026. By pooling data from multiple studies rather than relying on any single cohort, a meta-analysis offers a way to detect associations that individual investigations, often limited by small sample sizes or idiosyncratic populations, may miss or exaggerate. In this case, the question the authors set out to answer was deceptively simple: are children with atopic dermatitis more likely to be anemic than children without the disease?

The biological plausibility of such a link rests on several well-characterized mechanisms. Chronic inflammatory diseases are known to suppress red blood cell production through a cascade involving inflammatory cytokines such as interleukin-6, which drives up hepcidin, a liver-derived hormone that blocks iron absorption in the gut and traps iron inside macrophages. The result is the so-called anemia of inflammation, in which iron is present in the body but unavailable for hemoglobin synthesis. Because atopic dermatitis is, at its core, a Th2-skewed inflammatory disorder involving interleukins 4, 13, and 31, researchers have hypothesized that severe or long-standing disease could tilt children toward this iron-restricted state.

There are other plausible routes as well. Food allergies, which frequently co-occur with atopic dermatitis and often lead to restrictive elimination diets, can reduce dietary iron intake during critical growth periods. Sleep disruption from nocturnal itching, a near-universal burden in moderate-to-severe eczema, may compound fatigue and complicate the clinical picture. Some children with severe disease receive systemic immunosuppressive therapy, which has its own hematologic considerations. And epidemiological work in adjacent fields, including studies linking obesity to iron deficiency, has reinforced the idea that chronic systemic inflammation and micronutrient status are intertwined in ways that single-organ views of disease tend to miss.

The empirical foundation for the new analysis comes from several influential studies. A 2016 analysis published in JAMA Pediatrics by Drury, Schaeffer, and Silverberg reported an association between atopic disease and anemia in United States children, drawing on nationally representative data and igniting interest in extracutaneous manifestations of eczema. In 2022, Yang and colleagues, writing in the journal Nutrients, examined more than one hundred thousand children in the Japan Environment and Children’s Study and reported findings on allergic disorders and anemia risk in Japanese children. More recently, a 2024 study in Allergy by Kim and colleagues traced the cascade of atopic dermatitis comorbidities in children over fifteen years of life, documenting how the disease’s impact accumulates across organ systems as children grow.

By systematically identifying, appraising, and statistically combining studies of this relationship, the Stony Brook team aimed to move the field from scattered, sometimes conflicting single-cohort findings toward a more stable estimate of the association. Meta-analytic synthesis is particularly valuable in dermatology, where outcome definitions, anemia cutoffs based on age- and sex-specific hemoglobin thresholds, and eczema severity measures vary considerably between studies. Heterogeneity across included studies is therefore a central concern in any such analysis, and the authors’ work arrives amid ongoing methodological debate about how best to harmonize pediatric hematologic and dermatologic data.

Why does this matter clinically? Anemia in childhood is not a trivial finding. Even mild iron deficiency, with or without frank anemia, has been linked in the pediatric literature to impairments in cognitive development, attention, and school performance, and these deficits may not be fully reversible with iron repletion if they occur during sensitive developmental windows. If children with moderate-to-severe atopic dermatitis carry an elevated risk of anemia, that would argue for a lower threshold to check hemoglobin and iron studies in this population, particularly in children with refractory disease, restrictive diets, or symptoms such as fatigue and pallor that might otherwise be attributed to poor sleep alone.

The research letter also speaks to a broader conceptual shift in how the medical community understands atopic dermatitis. Over the past decade, the so-called atopic march, the progression from eczema to food allergy, allergic rhinitis, and asthma, has been joined by recognition of non-allergic comorbidities including anxiety, depression, obesity, and cardiovascular risk markers. Atopic dermatitis is increasingly framed as a systemic inflammatory disease with cutaneous manifestations rather than a skin disease with occasional allergic accompaniments. Anemia, if robustly associated, would fit neatly into this expanded comorbidity map and would add hematologic surveillance to the growing list of extracutaneous monitoring considerations for pediatric dermatologists and primary care clinicians alike.

At the same time, the authors and the field face important caveats. An association observed across observational studies does not establish that eczema causes anemia; reverse causation, confounding by diet, socioeconomic status, or shared environmental exposures, and selection bias in clinic-based samples all remain live possibilities. The referenced literature itself illustrates the complexity: the autoimmune and immunosuppressive pathways relevant to aplastic anemia, reviewed by Pan and colleagues in 2023, are distinct from the iron-restriction biology most relevant to eczema, and conflating different anemia subtypes could muddy pooled estimates. The Stony Brook authors declared no competing interests and reported no external funding for the work, and the article’s supplementary material provides additional methodological detail for readers who wish to interrogate the synthesis themselves.

For families, the practical takeaway is not alarm but attentiveness. Eczema affects a substantial fraction of children worldwide, and most will never develop hematologic problems. Yet the accumulating evidence base, now bolstered by this systematic review and meta-analysis, suggests that the itch that keeps a child awake at night may be one visible thread in a wider web of systemic effects. Clinicians managing pediatric atopic dermatitis may increasingly weigh simple laboratory screening alongside topical and systemic therapies, while researchers pursue the longitudinal studies needed to determine whether treating the skin more aggressively, particularly with the newer biologic and oral agents that suppress type 2 inflammation, might also protect the blood. The full study is available in Archives of Dermatological Research under DOI 10.1007/s00403-026-04939-3.

Subject of Research: The association between pediatric atopic dermatitis and anemia

Article Title: The association between atopic dermatitis with anemia in pediatric patients: a systematic review and meta-analysis

Article References: Chu, D., Yu, A., Guo, W., Salvemini, J., Hugh, J., & Shah, N. (2026). The association between atopic dermatitis with anemia in pediatric patients: a systematic review and meta-analysis. Archives of Dermatological Research, 318(1), Article 442. https://doi.org/10.1007/s00403-026-04939-3

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04939-3

Keywords: atopic dermatitis, anemia, pediatrics, meta-analysis, systematic review, eczema, iron deficiency, inflammation, comorbidities, dermatology, hemoglobin, child health